CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	3 Months Ended				9 Months Ended		12 Months Ended
	Sep. 30, 2023	Mar. 31, 2023	Sep. 30, 2022	Mar. 31, 2022	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Cash Flows Used in Operating Activities
Net loss	$ (10,848)	$ (17,178)	$ (17,993)	$ (11,557)	$ (35,355)	$ (49,880)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization					834	1,008
Amortization of intangible assets					1,476	4,559
Amortization of right-of-use asset					206	536
Stock based compensation	200		700		797	2,962
Amortization of warrant liability to redemption value					20	0
Earnout expense valuation benefit					0	(2,827)
Gain on settlement with FOXO					(1,142)	0
Amortization of debt issuance costs					2,103	121
Accrued interest income, related party					0	(278)
Unrealized gain on note					0	1,870
Unrealized loss on foreign currency transactions					176	0
Distribution of equity method investment shares to employees as compensation					666	0
Deferred income tax					2,591	(1)
Unrealized (gain) loss on equity securities	(5,791)		5,854		(5,733)	7,110
Impairment of goodwill					0	7,570
Gain on fair value of warrant liability					71	0
Realized loss on sale of equity securities	6,692		151		6,692	151
Gain on conversion of note receivable					0	(791)
Loss on exchange of debt for equity					124	0
Other					24	202
Changes in operating assets and liabilities:
Accounts receivable and other receivables					(652)	336
Inventory					(951)	(1,002)
Prepaid expenses and other current assets					1,110	1,545
Other assets					3	28
Accounts payable					(372)	237
Accrued liabilities					2,018	1,059
Income tax liabilities					(119)	(38)
Deferred revenue					530	(915)
Operating lease obligation					(207)	(505)
Net Cash Used in Operating Activities					(25,090)	(26,943)
Cash Flows Used in Investing Activities
Purchase of property and equipment					(142)	(221)
Investment in capitalized software					(135)	(611)
Purchase of convertible note					0	(5,500)
Sales of equity securities					323	229
Sales of treasury bills					0	43,001
Proceeds from repayment of note receivable					150	0
Issuance of note receivable					(2,025)	(150)
Net Cash (Used in) Provided By Investing Activities					(1,829)	36,748
Cash From Financing Activities
Net proceeds from issuance of preferred stock					0	46,906
Net proceeds from promissory note					125	5,539
Net proceeds from ATM stock offerings					26,510	0
Cash paid for redemption of preferred stock series 7					0	(49,250)
Taxes paid related to net share settlement of restricted stock units					0	(336)
Net proceeds from the issuance of warrants					1,409	0
Repayment of CXApp acquisition liability					(197)	(1,957)
Distribution to shareholders related to spin-off of CXApp					(10,003)	0
Common shares issued for exercise of warrants					2,341	0
Net Cash Provided By Financing Activities					20,185	902
Effect of Foreign Exchange Rate on Changes on Cash					(12)	(34)
Net (Decrease)/Increase in Cash and Cash Equivalents					(6,746)	10,673
Cash and Cash Equivalents - Beginning of period		$ 20,235		$ 52,480	20,235	52,480	$ 52,480
Cash and Cash Equivalents - End of period	$ 13,489		$ 63,153		13,489	63,153	$ 20,235
Cash paid for:
Interest					0	2
Income Taxes					10	100
Non-cash investing and financing activities
Common shares issued for extinguishment of debt					6,624	3,250
Noncash debt modification fees					144	0
Marketable securities received for settlement of FOXO					1,142	0
Common shares issued for CXApp Earnout Payment					0	3,697
Common shares issued in exchange for warrants					0	14
Right of use asset obtained in exchange for lease liability					0	284
Noncash exercise of liability classified warrants to common shares					90	0
Investment in equity securities through conversion of note receivable					0	6,776
Noncash net assets distribution to shareholders related to spin-off of CXApp					$ 14,227	$ 0